Celldex Therapeutics (CLDX) Stock: Buy, Sell, or Hold?
CLDX - Celldex Therapeutics, Inc
$29.37
-0.92 (-3.04%)
▼
5d:
+5.51%
30d:
-12.35%
90d:
-17.08%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 09, 2026
17d
Get Alerted When CLDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CLDX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CLDX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CLDX is currently trading at $29.37, which is considered slightly low relative to its 30-day fair value range of $29.01 to $36.56.
Technical Outlook: Technically, CLDX is in a uptrend. Immediate support is located at $27.46, while resistance sits at $30.82. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: CLDX scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $63.07 (+114.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CLDX is in a uptrend. Immediate support is located at $27.46, while resistance sits at $30.82. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: CLDX scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $63.07 (+114.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$29.01 -
$36.56
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 114.7% below Wall St target ($63.07)
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$29.01 -
$36.56
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$27.47
Resistance Level
$30.82
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.91
Wall Street Target
$63.07
(+114.7%)
Revenue Growth (YoY)
-97.0%
Share & Embed Analysis
Last updated: October 21, 2026 7:23 PM ET
Data refreshes hourly during market hours. Next update: 8:23 PM
Data refreshes hourly during market hours. Next update: 8:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 71 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 69 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 58 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 68 BUY |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 63 BUY |
